HSA ~37.09LMN-213DClinical Multi-Strain Probiotic (50 Billion CFU)
Delayed-release clinical probiotic with clinically studied Lactobacillus, Bifidobacterium, and Saccharomyces strains
Effective microbiome protocols match the organism class to the clinical context: non-bacterial yeast Saccharomyces boulardii resists antibacterial destruction during antibiotic courses, while soil-based Bacillus spores survive gastric acidity with low D-lactate SIBO bloating risk.
| Organism / Class | Antibiotic Compatibility | Primary Clinical Focus |
|---|---|---|
| Saccharomyces boulardii (CNCM I-745) | Resistant (beneficial yeast; immune to antibacterial drugs) | Antibiotic-associated diarrhea defense & IgA mucosal support |
| Bacillus Spore-Forming Strains | Stable spore coat (dose 2 hrs from antibiotics) | SIBO-friendly microbiome balance & tight-junction butyrate signaling |
| Lactobacillus + Bifidobacterium (50B CFU) | Dose strictly 2+ hours apart from antibiotics | Broad-spectrum daily colonic diversity & bowel regularity |
| L-Glutamine + Tributyrin + Zinc Carnosine | Non-living mucosal & enterocyte fuel | Post-infectious gut barrier repair & luminal soothing |
Tangible manufacturer-verified physical supplies eligible for ~30% pre-tax HSA/FSA reimbursement with instant Letter of Medical Necessity generation.
HSA ~37.09LMN-213DDelayed-release clinical probiotic with clinically studied Lactobacillus, Bifidobacterium, and Saccharomyces strains
HSA ~37.79LMN-213DSoothing enterocyte repair powder/capsules with L-Glutamine, Zinc Carnosine, and DGL for gastric and intestinal mucosa
HSA ~34.29LMN-213DClean physician-grade pediatric multivitamin, DHA, and probiotic formulas for children's cognitive and immune development
HSA ~41.99LMN-213DPharmaceutical-purity Tauroursodeoxycholic Acid (500mg) to support healthy hepatocyte function, bile acid conjugation, and liver enzyme balance.
HSA ~16.79LMN-213DClinically studied probiotic yeast Saccharomyces boulardii (10 Billion CFU) + MOS to protect intestinal tight junctions during and after antibiotic therapy.
HSA ~20.99LMN-213DTargeted Akkermansia muciniphila + prebiotic polyphenols to fortify colonic mucin barrier integrity and healthy metabolic glycemic signaling.
HSA ~34.29LMN-213DEnteric-targeted Tributyrin (900mg) providing sustained colonic butyrate release for colonocyte energy, tight-junction repair, and microbiome balance.
HSA ~30.79LMN-213DCold-processed bioactive Colostrum & Immunoglobulin G (IgG) powder/capsules for intestinal barrier restoration and upper-respiratory immune defense.
HSA ~37.09LMN-213D100% spore-based broad-spectrum Bacillus probiotic clinically shown to survive stomach acid, reduce post-meal endotoxemia, and support SIBO-sensitive patients.
HSA ~15.39LMN-213DEnteric-coated Mediterranean Wild Oregano Oil (standardized to 70% Carvacrol) for targeted small-intestinal microbial balance and post-meal bloating relief.
HSA ~29.39LMN-213DTargeted Ox Bile extract (125mg cholic acid conjugate), Pancreatic Lipase, and Artichoke Cynarin for complete dietary fat emulsification and Vitamin A/D/E/K absorption.
HSA ~41.29LMN-213DSoothing botanical demulcent powder/capsules combining Slippery Elm bark, Marshmallow root mucilage, and decolorized Aloe Vera to coat and protect sensitive esophageal and gastric tissue.
HSA ~46.19LMN-213DPhysician-formulated GLP-1 antiemetic and prokinetic complex with standardized Gingerols, Artichoke Leaf Extract, and active P-5-P Vitamin B6 for dose-escalation comfort.
HSA ~29.39LMN-213DPhysician-formulated hepatobiliary and digestive enzyme protocol combining TUDCA, purified Ox Bile, and high-lipase Pancreatin to support healthy bile fluidity during weight loss.
HSA ~16.79LMN-213DPhysician-built antibiotic companion combining antibiotic-proof Saccharomyces boulardii CNCM I-745 (10B CFU), endospore Bacillus strains, and L-Glutamine mucosal fuel.
HSA ~18.89LMN-213DHepatologist-formulated MASLD / Fatty Liver clearance protocol featuring Silybin Milk Thistle Phytosome, TUDCA, Annatto Delta-Tocotrienols, and Phosphatidylcholine.
Saccharomyces boulardii CNCM I-745 is a yeast that antibiotics cannot kill, so it can be started alongside an antibiotic course. Bacterial multi-strain probiotics should be separated by at least 2 hours from antibiotic doses and continued for 2–4 weeks afterward.
Explore companion ingredient categories or screen prescription nutrient depletions across 292 protocols.